• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].

作者信息

Kim Soong-Hoon, Johnson James A, Jiang Ji, Parkhurst Brandon, Phillips Monique, Pi Zulan, Qiao Jennifer X, Tora George, Ye Chen Alice, Liu Eddie, Yin Xiaohong, Yang Richard, Zhao Lei, Taylor David S, Basso Michael, Behnia Kamelia, Onorato Joelle, Chen Xue-Qing, Abell Lynn M, Lu Hao, Locke Gregory, Caporuscio Christian, Adam Leonard P, Gordon David, Wexler Ruth R, Finlay Heather J

机构信息

Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States.

Research and Development, Bristol-Myers Squibb, Princeton, NJ 08543, United States.

出版信息

Bioorg Med Chem Lett. 2019 Sep 1;29(17):2525. doi: 10.1016/j.bmcl.2019.07.032. Epub 2019 Jul 25.

DOI:10.1016/j.bmcl.2019.07.032
PMID:31353296
Abstract
摘要

相似文献

1
Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].
Bioorg Med Chem Lett. 2019 Sep 1;29(17):2525. doi: 10.1016/j.bmcl.2019.07.032. Epub 2019 Jul 25.
2
Corrigendum to "Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors" [Bioorg. Med. Chem. Lett. 31 (2021) 127710].对“鉴定2-取代吡咯并[1,2-b]哒嗪衍生物作为新型PARP-1抑制剂”[《生物有机与药物化学快报》31 (2021) 127710]的勘误
Bioorg Med Chem Lett. 2022 Jan 15;56:128501. doi: 10.1016/j.bmcl.2021.128501. Epub 2021 Dec 12.
3
Corrigendum to "Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors" [Bioorg. Med. Chem. Lett. 60 (2022) 128549].
Bioorg Med Chem Lett. 2022 Sep 15;72:128856. doi: 10.1016/j.bmcl.2022.128856. Epub 2022 Jun 18.
4
Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097].
Bioorg Med Chem Lett. 2017 Jul 15;27(14):3205. doi: 10.1016/j.bmcl.2017.05.056. Epub 2017 May 24.
5
Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995-1000].《“发现并优化一种用于潜在治疗神经损伤的强效、选择性且口服生物可利用的RARβ激动剂”的勘误》[《生物有机与药物化学快报》29(8) (2019) 995 - 1000]
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2440-2441. doi: 10.1016/j.bmcl.2019.05.058. Epub 2019 Jun 14.
6
Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675].
Bioorg Med Chem Lett. 2020 Jan 15;30(2):126771. doi: 10.1016/j.bmcl.2019.126771. Epub 2019 Dec 16.
7
Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580].
Bioorg Med Chem Lett. 2020 Aug 15;30(16):127363. doi: 10.1016/j.bmcl.2020.127363. Epub 2020 Jun 23.
8
Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].《新型查尔酮取代苯磺酰胺的合成及其碳酸酐酶抑制活性》的勘误 [《生物有机与药物化学快报》26 (2016) 5867 - 5870]
Bioorg Med Chem Lett. 2017 Aug 15;27(16):3944. doi: 10.1016/j.bmcl.2017.02.074. Epub 2017 Jul 10.
9
Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683].《针对falcilysin的强效哌嗪衍生异羟肟酸抑制剂的结构导向开发》的勘误[《生物有机与药物化学快报》32 (2021) 127683]
Bioorg Med Chem Lett. 2021 Apr 1;37:127836. doi: 10.1016/j.bmcl.2021.127836. Epub 2021 Feb 13.
10
Corrigendum to "Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors" [Bioorg. Med. Chem. Lett. 30 (2020) 127551].
Bioorg Med Chem Lett. 2021 Oct 1;49:128262. doi: 10.1016/j.bmcl.2021.128262. Epub 2021 Aug 2.